Blogs are written for an informed audience while remaining accessible to policymakers, licensees, and analysts.

Gathering Strain Data from Leafly

What consumer strain databases reveal — and obscure — about cannabis chemistry and perceived quality

Leafly

Strains

Cannabinoids

Ratings

Using several thousand strain records from Leafly, this analysis examines how THC and CBD percentile measures, product form, and labeled effects relate to consumer ratings. Results show that potency dominates perceived quality, while strain names and effect labels explain relatively little variation — highlighting the limits of consumer-facing strain taxonomies for market analysis and policy design.

January 24, 2026

Explaining the Importance of Integrators to the Washington Cannabis Industry

An exploration of integrators across Washington’s cannabis industry and CCRS

CCRS

Integrators

Compliance

In Washington, integrators exist because CCRS is a regulatory reporting hub—not a seed-to-sale system—and integrators are the technical translators that turn diverse…

January 18, 2026

Washington Cannabis Is Selling Less With More Participants

What the Second Half of 2025 Transaction Data Reveals About a Market Under Structural Stress

Market Structure

Retail

Wholesale

Supply Chain

CCRS transaction data indicates Washington cannabis is transitioning from a growth-oriented market to a zero-sum, margin-constrained market. The defining feature of this…

January 4, 2026

What CCRS Lab Data Really Tells Us About Cannabis Strains, Potency, and Product Form

Using Washington CCRS data to separate genetics, marketing labels, and market reality

Lab Results

Strains

THC

CBD

This analysis uses Washington’s CCRS lab testing data to examine how reported strain labels and product form align with observed cannabinoid potency and chemotype outcomes. By separating genetic intent from marketing conventions, the report highlights where laboratory results reinforce—or contradict—commonly used strain classifications. The findings clarify what CCRS data can reliably tell us about cannabis genetics, potency, and real-world market behavior.

January 1, 2026

Capsule Sales & Discounting Behavior in Washington

Annual Trends, Pricing Pressure, and Market Segmentation (2021–2025)

Capsule

Sales

Price

Discount

This analysis examines retail and wholesale sales of cannabis capsule products in Washington from 2021 through 2025. By linking sales transactions to product definitions and licensee metadata, the report evaluates how capsule pricing, discounting, and volume vary by business (DBA), county, and product subcategory. The goal is to understand whether capsules behave as a premium, medical, or commoditized segment within the broader cannabis market.

December 29, 2025

Encapsulated Flow: Mapping Transport Flows in Washington’s Capsule Market

Production Cycles and Distribution Patterns (2021–2025)

Capsule

Supply Chain

Transportation

4Years

This analysis examines the movement of cannabis capsule products within Washington’s regulated supply chain. Capsule-specific trends reveal where losses, bottlenecks, and high-volume transfer hubs emerge among licensees, offering actionable insight into capsule operations and regulatory oversight.

December 28, 2025

Data Security and Accuracy in Cannabis Analytics

The Technology Behind The Evergreen Canna Ledger Reports

CCRS

Security

Data Policy

In the fast-paced world of industry-level reporting of cannabis movements to state agencies and regulators, publicly-available data is more than just numbers. For us, it’s…

December 27, 2025

What Massachusetts’ 4/20 Cannabis Sales Reveal About Consumer Behavior in 2025

A view of cannabis holiday sales activity in an east coast state

Metrc

Holiday

Massachusetts

The 4/20 Surge — and the Slide That Follows

December 26, 2025

Washington Cannabis Licensee Behavior Typology

Classifying CCRS Submission Patterns Across the Retail Ecosystem

CCRS

Licensees

Market Structure

This report develops a data-driven typology of Washington cannabis licensees based on CCRS submission behavior. Using monthly submission volume, volatility, persistence, and trend direction, we identify three stable behavioral archetypes that describe how licensees interact with the traceability system over time.

December 12, 2025

Lab Results and Product Quality Correlation

Do medical products have higher test values than non-medical?

Cannabis

Lab Results

Quality

Medical

This analysis joins lab results with inventory to compare the chemical profiles (e.g., THC, CBD) of medical and non-medical cannabis. Summary statistics and visualizations help reveal quality differences across categories.

December 6, 2025